Assay |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Results |
Specimen
3h:
embryonic day 7.5; Foxa2tm1(cre/ERT2)Hssk/Foxa2+, Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+
(more
![]() Note: Conditional mutant. Tamoxifen (0.12 mg/g BW) was administered by gavage on E6.5. Embyros were isolated and stained on E7.5.
Specimen
3i:
embryonic day 8.5; Foxa2tm1(cre/ERT2)Hssk/Foxa2+, Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+
(more
![]() Note: Conditional mutant. Tamoxifen (0.12 mg/g BW) was administered by gavage on E6.5. Embyros were isolated and stained on E8.5.
Specimen
3j:
embryonic day 8.5; Foxa2tm1(cre/ERT2)Hssk/Foxa2+, Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+
(more
![]() Note: Conditional mutant. Tamoxifen (0.12 mg/g BW) was administered by gavage on E6.5. Embyros were isolated and stained on E8.5.
Specimen
3l:
embryonic day 9.5; Foxa2tm1(cre/ERT2)Hssk/Foxa2+, Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+
(more
![]() Note: Conditional mutant. Tamoxifen (0.12 mg/g BW) was administered by gavage on E6.5. Embyros were isolated and stained on E9.5.
Specimen
3m:
embryonic day 9.5; Foxa2tm1(cre/ERT2)Hssk/Foxa2+, Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+
(more
![]() Note: Conditional mutant. Tamoxifen (0.12 mg/g BW) was administered by gavage on E6.5. Embyros were isolated and stained on E9.5.
Specimen
3n:
embryonic day 9.5; Foxa2tm1(cre/ERT2)Hssk/Foxa2+, Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+
(more
![]() Note: Conditional mutant. Tamoxifen (0.12 mg/g BW) was administered by gavage on E6.5. Embyros were isolated and stained on E9.5.
Specimen
3o:
embryonic day 8.5; Foxa2tm1(cre/ERT2)Hssk/Foxa2+, Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+
(more
![]() Note: Conditional mutant. Tamoxifen (0.12 mg/g BW) was administered by gavage on E7.5. Embyros were isolated and stained on E8.5.
Specimen
3p:
embryonic day 9.5; Foxa2tm1(cre/ERT2)Hssk/Foxa2+, Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+
(more
![]() Note: Conditional mutant. Tamoxifen (0.12 mg/g BW) was administered by gavage on E8.5. Embyros were isolated and stained on E9.5.
Specimen
3q:
embryonic day 9.5; Foxa2tm1(cre/ERT2)Hssk/Foxa2+, Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+
(more
![]() Note: Conditional mutant. Tamoxifen (0.12 mg/g BW) was administered by gavage on E8.5. Embyros were isolated and stained on E9.5.
Specimen
3r:
embryonic day 9.5; Foxa2tm1(cre/ERT2)Hssk/Foxa2+, Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+
(more
![]() Note: Conditional mutant. Tamoxifen (0.12 mg/g BW) was administered by gavage on E8.5. Embyros were isolated and stained on E9.5.
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 03/18/2025 MGI 6.24 |
![]() |
|